Search research articles
Contact Us
Filters
Showing results (261-270 of 338) with videos related to
Page
of 34
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2019
Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma
Elizabeth R Gerstner, Kyrre E Emblem, Ken Chang, et al.
NPJ Precision Oncology
|
October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy
Theodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
Scientific Reports
|
November 22, 2018
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
K Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Scientific Reports
|
June 15, 2019
Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
K Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
NPJ Breast Cancer
|
August 26, 2021
Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study
Romualdo Barroso-Sousa, Tanya E Keenan, Tianyu Li, et al.
Oncotarget
|
April 23, 2021
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
Yehia I Mohamed, Sunyoung Lee, Lianchun Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2022
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
John D Martin, Ryan M Lanning, Vikash P Chauhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2026
Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Cancers
|
October 14, 2023
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine, et al.
Page
of 34
Search research articles
Search
Showing results (261-270 of 338) with videos related to
Sort By:
Page
of 34
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2019
Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma
Elizabeth R Gerstner, Kyrre E Emblem, Ken Chang, et al.
NPJ Precision Oncology
|
October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy
Theodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
Scientific Reports
|
November 22, 2018
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
K Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Scientific Reports
|
June 15, 2019
Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
K Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
NPJ Breast Cancer
|
August 26, 2021
Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study
Romualdo Barroso-Sousa, Tanya E Keenan, Tianyu Li, et al.
Oncotarget
|
April 23, 2021
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
Yehia I Mohamed, Sunyoung Lee, Lianchun Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2022
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
John D Martin, Ryan M Lanning, Vikash P Chauhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2026
Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Cancers
|
October 14, 2023
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine, et al.
Page
of 34